|
We are a national coalition of AIDS activists, many living with HIV/AIDS,working together to end the AIDS epidemic by advancing research on HIV/AIDS |
News
Member Log-in
Search
|
Bristol-Myers SquibbCommunity Affairs Manager: Jessica Riviere
Approved Drugs: 1) Atripla® (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) Tablets 2) Baraclude® (entecavir) Nucleoside analogue. Tablets and Oral Solution for Hep B 3) Reyataz® (atazanavir sulfate) Protease inhibitor (PI). Capsules 4) Sustiva® (efavirenz) Non-nucleoside reverse transcriptase inhibitor (NNRTI). Capsules and Tablets
Patient Assistance Program:
Telephone: 888-281-8981 (Baraclude, Reyataz, and Sustiva); 866-290-4767 (Atripla)
Website: http://www.bms.com/static/patient_assistance/data/programs.html Corporate website: www.bms.com
|